Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Submucosal Dexamethasone for Post-operative Sequelae After Mandibular Third Molar Surgery
NCT07258498Phase 4Completed
- Sponsor
- PAEC General Hospital
- Start
- Oct 2024
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone in Impacted Mandibular Third Molar (IM3M), sponsored by PAEC General Hospital. Started Oct 2024; status: completed.
02
Drugs
dexamethasone
03
Conditions
Impacted Mandibular Third Molar (IM3M)
Beyond the preview
Go deeper on NCT07258498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07258498.